Navigation Links
Program may hold promise for reducing avoidable hospital readmissions
Date:7/21/2013

Recent federal legislation imposes financial penalties on hospitals that experience excessive patient readmissions within 30 days. A new study published today in the Journal of Hospital Medicine looks at the potential of a program designed to improve the discharge process and prevent avoidable rehospitalizations.

Developed by the Society of Hospital Medicine, Project BOOST (Better Outcomes by Optimizing Safe Transitions) Mentoring Program focuses on identifying patients at highest risk for readmissions, communicating discharge plans effectively, and ensuring close follow-up through phone calls and timely doctors' appointments. An integral component is the use of physician mentors to facilitate implementation of BOOST tools at participating hospitals. To assess the effectiveness of BOOST, researchers studied hospitals varying in geography, size, and academic affiliation that implemented BOOST. While 30 hospitals had implemented the program when the study was initiated, only 11 were able to provide hospital unitspecific data for the study. Notably, hospitals received no funding to participate in BOOST.

The investigators found that the average rate of 30 day rehospitalization in BOOST units was 14.7 percent prior to implementing the program and 12.7 percent twelve months later, reflecting an absolute reduction of 2 percent and a relative reduction of 13.6 percent. Rehospitalization rates for similar hospital units that did not implement BOOST were 14.0 percent in the pre-intervention period and 14.1 percent in the post-intervention period. The average absolute reduction in readmission rates in BOOST units compared with other units was 2.0 percent, or a nearly 14 percent relative reduction.

"Our findings support that among the sites willing and able to share the outcome data required for the study, there was significant improvement," said lead BOOST analyst Luke Hansen, MD, MHS, of the Northwestern University Feinberg School of Medicine. "There is more work to do to fully engage non-academic sites in quality improvement research like ours and to understand what makes for fertile ground for implementing changes included in the BOOST toolkit."

"We are encouraged by our initial findings and learned substantially from this initial implementation and evaluation," added BOOST Principal Investigator, Mark V. Williams, MD, MHM, of the Northwestern University Feinberg School of Medicine. "Subsequent Project BOOST collaboration with greater than 130 hospitals has been modified and bolstered to increase the intensity of the BOOST intervention," he said.

In an accompanying editorial, Ashish Jha, MD, MPH, of the Harvard School of Public Health, noted that the study's findings suggest only a small improvement among a very select group of hospitals. "Hospitals will need to find ways to reduce readmissions, and programs like BOOST, even when executed perfectly, will be necessary but likely insufficient. Improving the quality of care transitions is critically important. But to truly get to better outcomes for older Americans, hospitals will need to think beyond their four walls," he wrote.

In another accompanying editorial, Andrew Auerbach, MD, MPH, of the UCSF School of Medicine, and his colleagues pointed to several shortcomings, but they stated that "the authors provide the necessary start down the road towards a fuller understanding of real world efforts to reduce readmissions. The nuances and flaws of this study provide ample fodder for others working in the field."


'/>"/>

Contact: Amy Molnar
sciencenewsroom@wiley.com
Wiley
Source:Eurekalert

Related medicine news :

1. Screening programs detect cases of undiagnosed rheumatic heart disease in low-resource countries
2. Ivy Neurological Sciences Internship program funded at TGen
3. Brief training program improves resident physicians empathy with patients
4. Southeast program to fight diabetes awarded nearly $10 million by HHS
5. Program to coordinate regional systems to speed heart attack care
6. Fewer prostate cancer surgery complications found in teaching hospitals with fellowship programs
7. UC San Diego Superfund Research Program receives $15 million grant renewal
8. UCLA launches first face transplantation program in western US
9. Rutgers leads effort to replicate care management programs in 4 U.S. cities
10. Steffi Nossen School of Dance Gears Up for Summer with Exciting Programming for All Ages
11. Coronary rehabilitation programs in Europe are underused
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2017)... (PRWEB) , ... August 19, 2017 , ... Yesterday, the ... KKK by saying there are two sides. There are not two sides to hatred, ... to rationalize violence and prejudice, and the NPEIV stands against all forms of such ...
(Date:8/19/2017)... ... August 19, 2017 , ... “Congratulations! It's A Boy! God’s Gift: A Story ... parents and God. “Congratulations! It's A Boy! God’s Gift: A Story of Love” is ... Island, New York. , Published by Christian Faith Publishing, Dale Anthony and Rachael Anthony’s ...
(Date:8/18/2017)... (PRWEB) , ... ... ... For Immediate ... Polling Shows Young Women Seek Sex and Relationship Advice from ...
(Date:8/18/2017)... ... August 18, 2017 , ... August 18, 2017 — ... advocating for active, healthy lifestyles and highlighting the importance of proactive eye and ... impairments and shares the latest innovations in hearing aid technology. , According ...
(Date:8/18/2017)... ... August 18, 2017 , ... The Dawn Johnson Insurance Group, ... new charity drive to generate community support for efforts to educate the local population ... treatments for all types of cancer. , Each day in America, roughly 4,600 ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)...  Axium Pharmaceuticals Inc., the creator of the drug Truveta ... stages of an IPO. The United States ... cost of a prescription epilepsy drug being $450.00-$1200.00 for a one month ... AXIUM PHARMACEUTICALS, INC ... Another staggering figure is the fact that Americans spent $42 billion on ...
(Date:8/14/2017)... PETACH TIKVAH, Israel , Aug. 15, ... leading developer of adult stem cell technologies for neurodegenerative ... June 30, 2017. ... our pivotal Phase 3 trial to investigate NurOwn ® ... and Chief Executive Officer of BrainStorm. "We have agreements ...
(Date:8/8/2017)... Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company focused on ... the second quarter ended June 30, 2017. ... to date: Continued ... lead project, BL-8040: Announced plans to ... stem cell mobilization treatment for autologous bone-marrow transplantation in ...
Breaking Medicine Technology: